One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Immediate-release gabapentin only. Do not apply this table to Horizant or Gralise. Source summary and reproduced table use different boundary notation.
Immediate-release gabapentin, GRALISE and HORIZANT are not interchangeable renal protocols. HORIZANT also has indication-specific schedules.
What to reconcile: Select the actual formulation and indication before using a dose or dialysis instruction.
Open this note and its source referencesThe RX table prints greater-than-30 to 59 and greater-than-15 to 29 bands; dialysis supplements are paired to maintenance regimens.
What to reconcile: Confirm the exact boundary and matched supplement in the complete current product table; no automatic dose calculation is provided.
Open this note and its source referencesThe RX table prints >30 to 59 and >15 to 29; exactly 30 is not clearly assigned. The hemodialysis supplement also belongs with a selected maintenance regimen.
What to reconcile: Verify the current table rather than silently rounding into a band. Do not select a supplement without its corresponding maintenance context.
Open this note and its source referencesAdult postherpetic neuralgia: 300 mg once on day 1, twice on day 2, three times on day 3; subsequently titrate toward 600 mg three times daily as needed. Epilepsy in patients >=12 years: start 300 mg three times daily; usual maintenance 300-600 mg three times daily.
gabapentin:dm-ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388-1 · Source locator: 2.1-2.2
Cockcroft-Gault CrCl in mL/min; total daily doses: >=60, 900-3600 mg in three doses; >30-59, 400-1400 mg in two doses; >15-29, 200-700 mg once daily; at 15, 100-300 mg once daily. Below 15, reduce proportionately to CrCl.
gabapentin:dm-ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388-2 · Source locator: 2.3, Table 1
Use the renal maintenance schedule plus a supplement after each 4-hour HD session: for the five corresponding at-15 maintenance columns (100/125/150/200/300 mg), supplements are 125/150/200/250/350 mg. Do not treat these as interchangeable fixed supplements.
gabapentin:dm-ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388-3 · Source locator: 2.3, Table 1 and footnotes
The selected label literally prints >30-59 and >15-29. It does not separately resolve exactly 30; confirm a threshold-boundary regimen with the prescriber rather than silently rounding.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=gabapentin&s1=dm-ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388&h1=d7573cd749f536382fc2cd0250d3eb6760720c96a2b4a0a92e858d51b6e1c782